Your browser doesn't support javascript.
loading
Polatuzumab-bendamustine-rituximab as bridge to CD19-directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax.
Perriello, Vincenzo Maria; Falini, Lorenza; Ruggeri, Loredana; Sorcini, Daniele; Ballanti, Stelvio; Flenghi, Leonardo; Baffa, Nicodemo; Covarelli, Piero; Sportoletti, Paolo; Pierini, Antonio; Falini, Brunangelo.
Affiliation
  • Perriello VM; Hematology Section, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO) University of Perugia Perugia Italy.
  • Falini L; Hematology Section, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO) University of Perugia Perugia Italy.
  • Ruggeri L; Hematology Section, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO) University of Perugia Perugia Italy.
  • Sorcini D; Hematology Section, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO) University of Perugia Perugia Italy.
  • Ballanti S; Hematology Section, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO) University of Perugia Perugia Italy.
  • Flenghi L; Hematology Section, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO) University of Perugia Perugia Italy.
  • Baffa N; Department of PET-CT and Radiological and Laboratory Imaging Hospital Santa Maria della Misericordia Perugia Italy.
  • Covarelli P; Section of Oncology Surgery, Department of Medicine and Surgery University of Perugia Perugia Italy.
  • Sportoletti P; Hematology Section, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO) University of Perugia Perugia Italy.
  • Pierini A; Hematology Section, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO) University of Perugia Perugia Italy.
  • Falini B; Hematology Section, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO) University of Perugia Perugia Italy.
EJHaem ; 4(2): 559-562, 2023 May.
Article de En | MEDLINE | ID: mdl-37206291
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: EJHaem Année: 2023 Type de document: Article Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: EJHaem Année: 2023 Type de document: Article Pays de publication: États-Unis d'Amérique